Abbvie Inc.
ALLERGAN
Amgen Inc.
Astellas
AstraZeneca
Bristol-Myers Squibb Company
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
Janssen Global Service,LLC (Johnson and Johnson)
Merck Sharp and Dohme Corp.
Novartis AG
Pfizer Inc.
UCB SA
Published | Pages | Publisher | Report code |
---|---|---|---|
Aug 2024 | 168 | Diligence Insights | ASDR-667495 |
Abbvie Inc.
ALLERGAN
Amgen Inc.
Astellas
AstraZeneca
Bristol-Myers Squibb Company
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
Janssen Global Service,LLC (Johnson and Johnson)
Merck Sharp and Dohme Corp.
Novartis AG
Pfizer Inc.
UCB SA